Your browser doesn't support javascript.
loading
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.
Sacconi, Andrea; De Vitis, Claudia; de Latouliere, Luisa; di Martino, Simona; De Nicola, Francesca; Goeman, Frauke; Mottini, Carla; Paolini, Francesca; D'Ascanio, Michela; Ricci, Alberto; Tafuri, Agostino; Marchetti, Paolo; Di Napoli, Arianna; De Biase, Luciano; Negro, Andrea; Napoli, Christian; Anibaldi, Paolo; Salvati, Valentina; Duffy, Darragh; Terrier, Benjamin; Fanciulli, Maurizio; Capalbo, Carlo; Sciacchitano, Salvatore; Blandino, Giovanni; Piaggio, Giulia; Mancini, Rita; Ciliberto, Gennaro.
Afiliação
  • Sacconi A; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • De Vitis C; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • de Latouliere L; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • di Martino S; UOSD Clinical Pathology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • De Nicola F; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Goeman F; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Mottini C; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Paolini F; UOSD Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • D'Ascanio M; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Ricci A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Tafuri A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Di Napoli A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • De Biase L; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Negro A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Napoli C; Department of Medical-Surgical Sciences and of Translational Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
  • Anibaldi P; Hospital Direction and Clinical Departments, Sant'Andrea University Hospital, Rome, Italy.
  • Salvati V; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Duffy D; Institut Pasteur, Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Paris, France.
  • Terrier B; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre, University of Paris, Paris, France.
  • Fanciulli M; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Capalbo C; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Sciacchitano S; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Blandino G; Laboratory of Biomedical Research, Niccolò Cusano University Foundation, Rome, Italy.
  • Piaggio G; UOSD Oncogenomica ed Epigenetica, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. giovanni.blandino@ifo.gov.it.
  • Mancini R; UOSD SAFU, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. giulia.piaggio@ifo.gov.it.
  • Ciliberto G; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Cell Death Dis ; 12(11): 1019, 2021 10 29.
Article em En | MEDLINE | ID: mdl-34716309

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucócitos Mononucleares / Citocinas / COVID-19 / Anticorpos Antivirais / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucócitos Mononucleares / Citocinas / COVID-19 / Anticorpos Antivirais / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália